The efficacy of 2,3-dimercaptopropanol and D-penicillamine on methyl mercury induced neurological signs and weight loss.
D000818:Animals; D001835:Body Weight / Q000187:drug effects*; D004112:Dimercaprol / Q000627:therapeutic use*; D005260:Female; D008767:Methylmercury Compounds / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000506:poisoning; D009422:Nervous System Diseases / Q000139:chemically induced / Q000188:drug therapy*; D010396:Penicillamine / Q000627:therapeutic use*; D051381:Rats; D013997:Time Factors; D014018:Tissue Distribution
D008767:Methylmercury Compounds; D004112:Dimercaprol; D010396:Penicillamine